Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Patient with ovarian insufficiency: baby born after anticancer therapy and re-transplantation of cryopreserved ovarian tissue

View through CrossRef
Abstract Background The second major cause of death is cancer. In fact, the effectiveness of anticancer treatments and positive long-term prognosis for young women has increased. However, the problem of post-cancer infertility plays a significant role, because chemotherapy can be gonadotoxic and lead to the functional death of ovaries. There is potential key solution to this problem: cryopreservation of ovarian tissue before cancer therapy with re-implantation after convalescence. Data regarding cryopreservation and re-transplantation of ovarian tissue from patients with ovarian insufficiency is limited. The aim of this treatment was the re-transplantation of cryopreserved ovarian tissue after anticancer therapy of patient with ovarian insufficiency (56 IU/l FSH, 8 ng/l β-estradiol, < 1.1 ng/ml anti-Mullerian hormone, 1 primary follicle per 10mm3). Case presentation After the operation, four tissue fragments (10–16 × 8–13 × 1.0–1.2 mm) were cooled to 5 °C in the freezing medium (culture medium+ 6% ethylene glycol+ 6% dimethyl sulfoxide+ 0.15 M sucrose) for 24 h, frozen and thawed. Freezing was performed in four standard 5 ml cryo-vials with ice formation at − 9 °C, cooling from − 9 to − 34 °C at a rate of − 0.3 °C/min and plunging at − 34 °C into liquid nitrogen. After thawing in a 100 °C (boiling) water bath, the removal of cryoprotectants was performed in 0.5 M sucrose with 20 min. exposure in sucrose and 30 min. stepping rehydration. After thawing of one cryo-vial, part (5 mm3) of experimental ovarian tissue after 7 day in vitro culture was histological evaluated and two ovarian fragments (8 × 7 × 1.0 mm and 7 × 6 × 1.0 mm) were re-transplanted. The quantity of follicles after cryopreservation and in vitro culture was not increased (P > 0.1): it was found 1 primordial follicle in 5 mm3 of tissue. Thirty seven days after the re-transplantation of ovarian tissue, the restoration of the menstrual cycle of Patient W. was noted. Three months after the transplantation, the patient became spontaneously pregnant and delivered a healthy baby girl at term. Conclusions Described protocol of conventional cryopreservation of ovarian tissue can be used for treatment of patients with ovarian insufficiency.
Title: Patient with ovarian insufficiency: baby born after anticancer therapy and re-transplantation of cryopreserved ovarian tissue
Description:
Abstract Background The second major cause of death is cancer.
In fact, the effectiveness of anticancer treatments and positive long-term prognosis for young women has increased.
However, the problem of post-cancer infertility plays a significant role, because chemotherapy can be gonadotoxic and lead to the functional death of ovaries.
There is potential key solution to this problem: cryopreservation of ovarian tissue before cancer therapy with re-implantation after convalescence.
Data regarding cryopreservation and re-transplantation of ovarian tissue from patients with ovarian insufficiency is limited.
The aim of this treatment was the re-transplantation of cryopreserved ovarian tissue after anticancer therapy of patient with ovarian insufficiency (56 IU/l FSH, 8 ng/l β-estradiol, < 1.
1 ng/ml anti-Mullerian hormone, 1 primary follicle per 10mm3).
Case presentation After the operation, four tissue fragments (10–16 × 8–13 × 1.
0–1.
2 mm) were cooled to 5 °C in the freezing medium (culture medium+ 6% ethylene glycol+ 6% dimethyl sulfoxide+ 0.
15 M sucrose) for 24 h, frozen and thawed.
Freezing was performed in four standard 5 ml cryo-vials with ice formation at − 9 °C, cooling from − 9 to − 34 °C at a rate of − 0.
3 °C/min and plunging at − 34 °C into liquid nitrogen.
After thawing in a 100 °C (boiling) water bath, the removal of cryoprotectants was performed in 0.
5 M sucrose with 20 min.
exposure in sucrose and 30 min.
stepping rehydration.
After thawing of one cryo-vial, part (5 mm3) of experimental ovarian tissue after 7 day in vitro culture was histological evaluated and two ovarian fragments (8 × 7 × 1.
0 mm and 7 × 6 × 1.
0 mm) were re-transplanted.
The quantity of follicles after cryopreservation and in vitro culture was not increased (P > 0.
1): it was found 1 primordial follicle in 5 mm3 of tissue.
Thirty seven days after the re-transplantation of ovarian tissue, the restoration of the menstrual cycle of Patient W.
was noted.
Three months after the transplantation, the patient became spontaneously pregnant and delivered a healthy baby girl at term.
Conclusions Described protocol of conventional cryopreservation of ovarian tissue can be used for treatment of patients with ovarian insufficiency.

Related Results

Efektivitas Baby Massage Dan Baby Gym Terhadap Kualitas Tidur Bayi Usia 3-6 Bulan
Efektivitas Baby Massage Dan Baby Gym Terhadap Kualitas Tidur Bayi Usia 3-6 Bulan
Baby massage dan baby gym adalah upaya untuk meningkatkan kualitas tidur pada bayi.  Masalah tidur pada bayi di Indonesia cukup banyak, yaitu sekitar 44,2% bayi mengalami gangguan ...
Baby Massage and Baby Gym to Increase Infants Growth
Baby Massage and Baby Gym to Increase Infants Growth
ABSTRACTInfancy is a golden period as well as a critical period of growth and development. The number of babies born in 2021 in Indonesia is 4,438,141 people and in the area of Cen...
Autonomy on Trial
Autonomy on Trial
Photo by CHUTTERSNAP on Unsplash Abstract This paper critically examines how US bioethics and health law conceptualize patient autonomy, contrasting the rights-based, individualist...
Safety and Efficacy of Atezolizumab in Ovarian Cancer
Safety and Efficacy of Atezolizumab in Ovarian Cancer
Abstract Introduction Although the efficacy of PD-L1 blockade has been evaluated in analyses that combine pharmacologically distinct antibodies, the specific efficacy and safety of...
Pembrolizumab and Sarcoma: A meta-analysis
Pembrolizumab and Sarcoma: A meta-analysis
Abstract Introduction: Pembrolizumab is a monoclonal antibody that promotes antitumor immunity. This study presents a systematic review and meta-analysis of the efficacy and safety...

Back to Top